BRAF inhibitor shows promising results in pediatric patients with low-grade glioma
Dabrafenib (Tafinlar), a BRAF inhibitor approved to treat certain types of adult melanoma, showed activity in pediatric patients with low-grade glioma, according to results published in Clinical Cancer Research, a journal ...
Dec 6, 2019
0
3